Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Study of Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
TCTR20260114005Completed
- Sponsor
- Kamonwan Jutivorakool
- Start
- Jun 2023
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ceftazidime + avibactam in Gram-negative bacterial infection, sponsored by Kamonwan Jutivorakool. Started Jun 2023; status: completed.
02
Drugs
ceftazidime + avibactam
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on TCTR20260114005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260114005.